Recent lateral hires Gustavo Resendiz and Robert Linnoila were featured in legal and business press, including the Law360 article, “Foley & Lardner Adds Fund Pros From Choate In Boston.”
“Foley’s renowned national platform and both the full-service nature and specific client focus of the firm’s Fund Formation & Investment Management (FFIM) Practice positions the firm to address clients’ broad strategic objectives,” said Resendiz. “I’m excited to return to the firm and look forward to leveraging the FFIM platform and the depth of Foley’s broader capabilities for the betterment of our clients.”
Coverage of their move to the firm also appeared in Attorney at Law Magazine, Bloomberg Law, Global Legal Chronicle, Private Funds CFO, and Reuters.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”